EP 1737452 A1 20070103 - ANGIOGENESIS-AFFECTING COMPOUNDS AND METHODS OF USE THEREOF
Title (en)
ANGIOGENESIS-AFFECTING COMPOUNDS AND METHODS OF USE THEREOF
Title (de)
VERBINDUNGEN ZUR BEEINFLUSSUNG DER ANGIOGENESE UND ANWENDUNGSVERFAHREN
Title (fr)
COMPOSES AGISSANT SUR L'ANGIOGENESE ET PROCEDES D'UTILISATION DE CEUX-CI
Publication
Application
Priority
- SE 2005000506 W 20050406
- US 52134604 P 20040406
Abstract (en)
[origin: WO2005097121A1] Angiogenesis may be affected by administering a compound to a group of cells, a tissue or an organism. Such affect may be to inhibit or stimulate angiogenesis. The compounds may be used to treat disease states related to insufficient or unregulated angiogenesis.
IPC 8 full level
A61K 31/4402 (2006.01); A61K 31/445 (2006.01); A61K 31/7048 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61P 17/06 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 31/4402 (2013.01); A61K 31/445 (2013.01); A61K 31/7048 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 1/04 (2017.12); A61P 9/00 (2017.12); A61P 9/04 (2017.12); A61P 9/10 (2017.12); A61P 17/02 (2017.12); A61P 17/06 (2017.12); A61P 25/00 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2005097121A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005097121 A1 20051020; AU 2005230811 A1 20051020; CA 2560416 A1 20051020; CN 1938025 A 20070328; EP 1737452 A1 20070103; JP 2007532536 A 20071115; NZ 550088 A 20090828
DOCDB simple family (application)
SE 2005000506 W 20050406; AU 2005230811 A 20050406; CA 2560416 A 20050406; CN 200580010505 A 20050406; EP 05730890 A 20050406; JP 2007507279 A 20050406; NZ 55008805 A 20050406